Index | Ligand Name | Structure | PDB code | ligand desolvation |
1 | l96 | Crystal Structure of FABP4 in complex with 3-{5-cyclopropyl-3-(3,5-dimethyl-1H-pyrazol-4-yl)-2-[3-(propan-2-yloxy) phenyl]-1H-indol-1-yl}propanoic acid | 5d48 | 94.66 |
2 | 57p | Crystal Structure of FABP4 in complex with 3-(5-cyclopropyl-2,3-diphenyl-1H-indol-1-yl)propanoic acid | 5d45 | 94.57 |
3 | l19 | Crystal Structure of FABP4 in complex with 3-[5-cyclopropyl-3-(3-methoxypyridin-4-yl)-2-phenyl-1H-indol-1-yl] propanoic acid | 5d47 | 94.16 |
4 | 5m7 | human FABP4 in complex with 6-Chloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid at 1.29A | 5edc | 93.68 |
5 | 8ca | N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid Binding Protein (A-FABP) inhibitors | 3fr2 | 93.36 |
6 | i4a | N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid Binding Protein (A-FABP) inhibitors | 3fr5 | 93.22 |
7 | 65y | FABP4 in complex with 6-Chloro-2-isopropyl-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic acid | 5hz6 | 93.01 |
8 | 8jo | Crystal structure of human FABP4 complexed with ligand 2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid | 5y0f | 92.22 |
9 | 8jl | Crystal structure of human FABP4 complexed with ligand 4-Fluoro-3-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid | 5y0g | 91.94 |
10 | f8a | N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid Binding Protein (A-FABP) inhibitors | 3fr4 | 91.71 |
11 | 5m8 | human fatty acid binding protein 4 in complex with 6-Chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid at 1.18A | 5edb | 90.27 |
12 | b1v | Crystal structure of human adipocyte fatty acid binding protein in complex with a non-covalent ligand | 1tou | 87.64 |
13 | ibp | Human adipocyte lipid-binding protein FABP4 in complex with (S)-ibuprofen | 3p6h | 87.08 |
14 | izp | Human adipocyte lipid-binding protein FABP4 in complex with (R)-ibuprofen | 3p6g | 86.78 |